Shuttle Pharmaceuticals Holdings (SHPH) Other Non Operating Income (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Other Non Operating Income of $76264.0 in Q1 2026, up 183.67% quarter-over-quarter from -$91149.0 in Q4 2025, and up 2785.51% on a YoY basis from $2643.0 in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Other Non Operating Income (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Other Non Operating Income history runs 6 years deep, the most recent figure standing at $76264.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 2785.51% year-over-year to $76264.0; the TTM figure through Mar 2026 stood at -$785.0 (down 100.22% YoY), while the FY2025 annual figure was -$74406.0, down 113.39% from the prior year.
- Other Non Operating Income was $76264.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from -$91149.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.2 million in Q1 2023 to a low of -$283025.0 in Q4 2022.
- Historically, Other Non Operating Income has averaged $152066.8 across 5 years, with a median of $76264.0 in 2026.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income jumped 3029.89% in 2023, then plunged 142.32% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at -$283025.0 in 2022, then jumped by 134.74% to $98313.0 in 2023, then soared by 119.08% to $215384.0 in 2024, then slumped by 142.32% to -$91149.0 in 2025, then soared by 183.67% to $76264.0 in 2026.
- The last three Other Non Operating Income figures came in at $76264.0 (Q1 2026), -$91149.0 (Q4 2025), and $2427.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 2.17 Mn | 1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76,264.00 |
| Dec 31, 2025 | -91,149.00 |
| Sep 30, 2025 | 2,427.00 |
| Jun 30, 2025 | 11,673.00 |
| Mar 31, 2025 | 2,643.00 |
| Dec 31, 2024 | 215,384.00 |
| Sep 30, 2024 | 286,316.00 |
| Jun 30, 2024 | -143,773.00 |
| Mar 31, 2024 | 197,862.00 |
| Dec 31, 2023 | 98,313.00 |
| Sep 30, 2023 | 442,900.00 |
| Jun 30, 2023 | 434,275.00 |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | -283,025.00 |
| Sep 30, 2022 | 112,797.00 |
| Jun 30, 2022 | -58,422.00 |
| Mar 31, 2022 | 39,650.00 |
| Sep 30, 2021 | 62,500.00 |